ViewRay, Inc. (NASDAQ:VRAY) announced its quarterly earnings results on Monday. The company reported ($0.19) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.12) by ($0.07), Bloomberg Earnings reports. The company had revenue of $12.20 million for the quarter, compared to analysts’ expectations of $18.63 million. The company’s revenue for the quarter was up 2950.0% compared to the same quarter last year.
Shares of ViewRay (VRAY) opened at $8.00 on Wednesday. The company has a quick ratio of 1.45, a current ratio of 1.73 and a debt-to-equity ratio of -2.62. ViewRay has a one year low of $2.78 and a one year high of $10.39.
Several equities research analysts recently commented on the stock. reiterated a “buy” rating and set a $12.00 price target on shares of ViewRay in a research note on Monday. lowered shares of ViewRay from a “hold” rating to a “sell” rating in a research note on Friday, September 22nd. Finally, reiterated a “buy” rating and set a $11.00 price target on shares of ViewRay in a research note on Saturday, July 22nd. One investment analyst has rated the stock with a sell rating and five have issued a buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average price target of $10.00.
TRADEMARK VIOLATION WARNING: This piece was reported by Week Herald and is the sole property of of Week Herald. If you are accessing this piece on another domain, it was stolen and reposted in violation of US and international copyright and trademark law. The original version of this piece can be accessed at https://weekherald.com/2017/11/15/viewray-inc-vray-announces-quarterly-earnings-results-misses-expectations-by-0-07-eps.html.
Hedge funds and other institutional investors have recently bought and sold shares of the business. The Manufacturers Life Insurance Company acquired a new position in ViewRay in the second quarter valued at $159,000. California State Teachers Retirement System increased its stake in ViewRay by 280.5% in the second quarter. California State Teachers Retirement System now owns 51,819 shares of the company’s stock valued at $335,000 after purchasing an additional 38,200 shares during the period. Finally, State Street Corp increased its stake in ViewRay by 631.7% in the second quarter. State Street Corp now owns 395,418 shares of the company’s stock valued at $2,555,000 after purchasing an additional 341,376 shares during the period. Institutional investors own 53.88% of the company’s stock.
ViewRay, Inc designs, manufactures and markets MRIdian, the magnetic resonance imaging (MRI)-guided radiation therapy system to image and treat cancer patients simultaneously. The Company offers radiation therapy technology combined with magnetic resonance imaging. MRIdian integrates MRI technology, radiation delivery and the Company’s software to locate, target and track the position and shape of soft-tissue tumors while radiation is delivered.
Receive News & Ratings for ViewRay Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ViewRay Inc. and related companies with MarketBeat.com's FREE daily email newsletter.